chr7-55795943-A-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_207366.3(SEPTIN14):c.1269T>A(p.Asp423Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000144 in 1,594,736 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_207366.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SEPTIN14 | NM_207366.3 | c.1269T>A | p.Asp423Glu | missense_variant | 10/10 | ENST00000388975.4 | NP_997249.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SEPTIN14 | ENST00000388975.4 | c.1269T>A | p.Asp423Glu | missense_variant | 10/10 | 2 | NM_207366.3 | ENSP00000373627.3 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152220Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000206 AC: 48AN: 233066Hom.: 0 AF XY: 0.000219 AC XY: 28AN XY: 128028
GnomAD4 exome AF: 0.000139 AC: 201AN: 1442398Hom.: 2 Cov.: 28 AF XY: 0.000146 AC XY: 105AN XY: 718064
GnomAD4 genome AF: 0.000190 AC: 29AN: 152338Hom.: 0 Cov.: 31 AF XY: 0.000228 AC XY: 17AN XY: 74490
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 21, 2021 | The c.1269T>A (p.D423E) alteration is located in exon 10 (coding exon 9) of the SEPT14 gene. This alteration results from a T to A substitution at nucleotide position 1269, causing the aspartic acid (D) at amino acid position 423 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at